0 Yorumlar
0 hisse senetleri
1K Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Expanding Oncology Demand Boosts Immune Checkpoint Inhibitors Market ValueImmune checkpoint inhibitors are cutting-edge immunotherapies that strengthen the body’s natural defense mechanisms by inhibiting proteins that prevent immune cells from attacking cancer. By blocking checkpoints such as CTLA 4 and PD 1/PD L1, these treatments enhance T cell activation and tumor destruction. Their expanding clinical success is driving broader integration into combination...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
First-in-Class Oncology Drug market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"First-in-Class Oncology Drug Market Summary: According to the latest report published by Data Bridge Market Research, the First-in-Class Oncology Drug Market The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by...0 Yorumlar 0 hisse senetleri 349 Views 0 önizleme
-
First-in-Class Oncology Drug Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Global Executive Summary First-in-Class Oncology Drug Market: Size, Share, and Forecast The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery technologies, high unmet medical needs...0 Yorumlar 0 hisse senetleri 628 Views 0 önizleme
-
First-in-Class Oncology Drug Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Key Drivers Impacting Executive Summary First-in-Class Oncology Drug Market Market Size and Share The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery technologies, high unmet...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Generic Oncology Drugs Market Dynamics and Competitive Landscape Supporting US$ 42.43 Billion GrowthThe global Generic Oncology Drugs Market is witnessing remarkable growth due to the increasing prevalence of cancer worldwide and the rising demand for affordable treatment options. Healthcare systems across developed and emerging economies are actively adopting generic oncology drugs to reduce the financial burden associated with cancer therapies. The growing number of patent expirations for...0 Yorumlar 0 hisse senetleri 21 Views 0 önizleme
-
How Are Oncology Treatment Innovations Boosting the Europe Tumor Ablation Market?Global Executive Summary Europe Tumor Ablation Market: Size, Share, and Forecast CAGR Value The Europe tumor ablation market size was valued at USD 584.50 million in 2025 and is expected to reach USD 1,349.91 million by 2033, at a CAGR of 11.03% during the forecast period The Europe Tumor Ablation Market analysis report focuses on leading global industry players, providing information such...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Increasing Demand for Oncology Therapies Fuels High Potent Pharmaceuticals Product MarketThe global High Potent Pharmaceuticals Product Market is witnessing substantial growth due to increasing demand for targeted therapies, rising prevalence of chronic diseases, and expanding oncology drug development activities. High potent pharmaceutical products are widely used in the treatment of cancer, hormonal disorders, and various chronic conditions due to their high therapeutic efficacy...0 Yorumlar 0 hisse senetleri 19 Views 0 önizleme
-
Is the Epigenetics-Based Therapeutics Market Transforming Precision Medicine and Oncology?"Executive Summary Epigenetics-Based Therapeutics Market Research: Share and Size Intelligence CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The all-inclusive Epigenetics-Based Therapeutics Market...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Non-Small Cell Lung Cancer Market Is Expanding with Advancements in Oncology Therapies"Non-Small Cell Lung Cancer Market Summary: According to the latest report published by Data Bridge Market Research, the Non-Small Cell Lung Cancer Market CAGR Value Data Bridge Market Research analyses that the non-small cell lung cancer market which is USD 26948.36 million in 2022, is expected to reach USD 76334.72 million by 2030, at a CAGR of 13.9% during the forecast period...0 Yorumlar 0 hisse senetleri 256 Views 0 önizleme
-
5-Fluorouracil Market Outlook 2031: Growth Trends, Industry Dynamics, and Strategic OpportunitiesThe global 5-Fluorouracil market is witnessing steady expansion, driven by the increasing prevalence of cancer and the continued reliance on chemotherapy-based treatment protocols. 5-Fluorouracil (5-FU) remains one of the most widely used antimetabolite drugs in oncology, particularly for colorectal, breast, and gastrointestinal cancers. According to The Insight Partners, the market is expected...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Advancements in Biopharmaceuticals Accelerate the Global EPO Drugs MarketGlobal Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...0 Yorumlar 0 hisse senetleri 282 Views 0 önizleme
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Can RNA-Based Therapeutics Revolutionize Cancer Treatment?RNA-Based Cancer Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the RNA-Based Cancer Therapeutics Market CAGR Value For structuring the finest market research report like this RNA-Based Cancer Therapeutics Market, a devoted team of experienced forecasters, well-versed analysts and knowledgeable researchers work...0 Yorumlar 0 hisse senetleri 525 Views 0 önizleme
-
CAR-T Cell Therapy Market Demand Rising Across Global HealthcareExpanding healthcare infrastructure in emerging economies is creating new opportunities for the CAR-T cell therapy market. Countries in Asia-Pacific and Latin America are investing in advanced cancer treatment facilities. This expansion supports global market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell Therapy Market is witnessing...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Chemotherapy Induced Anemia Market Size, Trends, and Growth StrategiesThe chemotherapy induced anemia market is witnessing steady growth driven by rising cancer prevalence and advancements in anemia management therapies. Increasing demand for effective anemia treatment options and enhanced diagnostic capabilities are reshaping market dynamics, with notable shifts in market trends poised to influence business growth globally.Market Size and Overview The...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Dendritic Cell Cancer Vaccine Market Opportunities in Precision MedicinePharmaceutical companies are expanding their oncology pipelines to include dendritic cell vaccine therapies. Continuous research is leading to the discovery of new therapeutic targets. These advancements are strengthening the market. The Dendritic Cell Cancer Vaccine Market is gaining significant attention in the global oncology landscape as immunotherapy continues to revolutionize cancer...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Expanding Horizons in Adult Malignant Glioma Therapeutics Market: Growth Opportunities, Strategies, and Forecast to 2031The global oncology sector is undergoing a significant transformation, driven by the rising prevalence of aggressive brain tumors such as malignant gliomas in adults. Increasing incidence rates, coupled with advancements in immunotherapy, targeted therapies, and precision medicine, are shaping a dynamic treatment landscape. Pharmaceutical and biotechnology companies are focusing on developing...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
Arama Sonuçları
Sponsorluk
Sponsorluk
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek